Department of Neuroscience, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285-0510, USA.
Trends Neurosci. 2010 May;33(5):241-8. doi: 10.1016/j.tins.2010.02.004. Epub 2010 Mar 8.
Transmembrane AMPA receptor regulatory proteins (TARPs) are the first identified auxiliary subunits for a neurotransmitter-gated ion channel. Although initial studies found that stargazin, the prototypical TARP, principally chaperones AMPA receptors, subsequent research demonstrated that it also regulates AMPA receptor kinetics and synaptic waveforms. Recent studies have identified a diverse collection of TARP isoforms--types Ia, Ib II--that distinctly regulate AMPA receptor trafficking, gating and neuropharmacology. These TARP isoforms are heterogeneously expressed in specific neuronal populations and can differentially sculpt synaptic transmission and plasticity. Whole-genome analyses also link multiple TARP loci to childhood epilepsy, schizophrenia and bipolar disorder. TARPs emerge as vital components of excitatory synapses that participate both in signal transduction and in neuropsychiatric disorders.
跨膜 AMPA 受体调节蛋白 (TARPs) 是第一个被鉴定为神经递质门控离子通道辅助亚基的蛋白。尽管最初的研究发现,星状蛋白(TARP 的原型)主要作为 AMPA 受体的伴侣,但随后的研究表明它也调节 AMPA 受体动力学和突触波形。最近的研究已经确定了一组多样化的 TARP 同工型 - Ia、Ib II 型 - 它们明显调节 AMPA 受体的运输、门控和神经药理学。这些 TARP 同工型在特定神经元群体中呈现异质性表达,并能以不同的方式塑造突触传递和可塑性。全基因组分析还将多个 TARP 基因座与儿童癫痫、精神分裂症和双相情感障碍联系起来。TARPs 成为兴奋性突触的重要组成部分,参与信号转导和神经精神疾病。